Clinical Trial Update: Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a margin-intense combination therapy in patients with potentially resectable pancreatic cancer; the trial status is terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Pancreatic Cancer | Phase 1 | Status: TERMINATED